Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Completed Phase 1 Trials for Alvespimycin (DB12442)

IndicationStatusPhase
DBCOND0029527 (Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089362Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsTreatment